23.06.2015 – 24.06.2015
Venue: London, UK
The 6th AGAH Dermatological Product Development Workshop was held June 23-24, 2015, in London, UK. 71 participants from 12 countries helped make this international workshop focused on bridging strategies from early development to regulatory approval a resounding success. The workshop featured an outstanding speaker panel of experts from industry, academics and the MHRA.
Many of the current issues and challenges in the development of both innovative and generic topically applied drug products were addressed. Key approaches interlaced throughout the two-day workshop included
- Building confidence towards selection of clinical candidates using a tool-kit approach
- Risk mitigation strategies for major vs. minor formulation changes during development
- Indication specific development strategies
- Regulatory perspectives from both sides of the pond
The workshop provided a unique platform to discuss practical and regulatory aspects of dermatological development which are critical to risk mitigation and success of new products from the perspective of both big pharma and leading dermatology companies to small biotech start-ups. An engaged audience contributed to lively question and answer sessions with discussions continuing in the networking breaks.
The AGAH would like to especially thank the industry sponsors without whom this workshop would not have been possible as well as the speakers, moderators and attendees who contributed to making this workshop a huge success!